287 related articles for article (PubMed ID: 23372727)
1. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
[TBL] [Abstract][Full Text] [Related]
2. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
[TBL] [Abstract][Full Text] [Related]
3. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
[TBL] [Abstract][Full Text] [Related]
4. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
5. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
6. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
7. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4
Lo Re O; Mazza T; Giallongo S; Sanna P; Rappa F; Vinh Luong T; Li Volti G; Drovakova A; Roskams T; Van Haele M; Tsochatzis E; Vinciguerra M
Theranostics; 2020; 10(2):910-924. PubMed ID: 31903159
[No Abstract] [Full Text] [Related]
8. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.
Muir K; Hazim A; He Y; Peyressatre M; Kim DY; Song X; Beretta L
Cancer Res; 2013 Aug; 73(15):4722-31. PubMed ID: 23749645
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
[TBL] [Abstract][Full Text] [Related]
10. Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer.
Newberry EP; Hall Z; Xie Y; Molitor EA; Bayguinov PO; Strout GW; Fitzpatrick JAJ; Brunt EM; Griffin JL; Davidson NO
Hepatology; 2021 Sep; 74(3):1203-1219. PubMed ID: 33638902
[TBL] [Abstract][Full Text] [Related]
11. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD
J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698
[TBL] [Abstract][Full Text] [Related]
12. WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.
Abu-Remaileh M; Khalaileh A; Pikarsky E; Aqeilan RI
Cell Death Dis; 2018 May; 9(5):511. PubMed ID: 29724996
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice.
Watanabe S; Horie Y; Kataoka E; Sato W; Dohmen T; Ohshima S; Goto T; Suzuki A
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S96-S100. PubMed ID: 17567478
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
16. SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.
Pazienza V; Borghesan M; Mazza T; Sheedfar F; Panebianco C; Williams R; Mazzoccoli G; Andriulli A; Nakanishi T; Vinciguerra M
Aging (Albany NY); 2014 Jan; 6(1):35-47. PubMed ID: 24473773
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
Assante G; Chandrasekaran S; Ng S; Tourna A; Chung CH; Isse KA; Banks JL; Soffientini U; Filippi C; Dhawan A; Liu M; Rozen SG; Hoare M; Campbell P; Ballard JWO; Turner N; Morris MJ; Chokshi S; Youngson NA
Genome Med; 2022 Jun; 14(1):67. PubMed ID: 35739588
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
19. Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.
Orci LA; Lacotte S; Oldani G; Slits F; De Vito C; Crowe LA; Rubbia-Brandt L; Vallée JP; Morel P; Toso C
Br J Surg; 2016 Mar; 103(4):417-26. PubMed ID: 26891212
[TBL] [Abstract][Full Text] [Related]
20. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]